CoVID-19 impact on brain surveillance market 2020-2025

Dublin, 18 August 2020 (GLOBE NEWSWIRE) – The “market for brain tracking through products (device, MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, electrode, paste, gel, battery, cable, invasive), disease (TBI, stroke, dementia, epilepsy, headaches, sleep) and end user (hospital, clinic, ASC): the Global Forecasts to 2025 report “added to the offer of ResearchAndMarkets.com. The global brain surveillance market is expected to succeed at $8561.7 million through 2025 to $6336.4 million in 2020, with an annual compound rate of 6.2% during the forecasting period.

The brain tracking market is governed by some global players such as Natus Medical, Inc. (USA), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (USA), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (USA), Drgerwerk AG – Co. KGaA (Germany), Advanced Brain Monitoring (USA), Masimo Corporation (USA), Spiegelberg GmbH – Co. KG (Germany), Cadwell Industries (USA) Array NeuroWave Systems, Inc. (USA), Nonin Medical, Inc. (USA), Integra LifeSciences Corporation (USA), Neurosoft (Russia) and Rimed (USA) Topics

1 Introduction2 Research Methodology3 Analytical Summary4 Premium Perspectives4.1 Brain Surveillance: Market Overview4.2 Brain Surveillance Market, through Product4.3 Brain Surveillance Market, According to the end user4.4 Geographical overview of the global market Brain monitoring five.1 Introduction five.2 Market dynamics five.2.1 Engines five.2.1.1 Increased incidence and prevalence of neurological disorders five.five.1 2.1.2 Increased knowledge of neurodegenerative disorders five.2.1.3 Increased incidence of traumatic brain injury five.2.1.4 Increased applications five.2.2 Restrictions five.2.2. five.2.1 High cost of complex brain surveillance devices and procedures five.2.2.2 Five unfavourable reimbursement policies five.2.3 Opportunities five.2.3.1 Growing demand for non-invasive and mini-invasive devices five.2.3.2 Expansion of the therapeutic applications of Five Brain Surveillance Devices. 2.3.3 Growth of the health market in emerging economies five.2.4 Challenges five.2.4.1 Shortage of qualified professionals five.2.4.2 Problems similar to the approval and marketing of the i zation five.3 Impact of COVID-1nine on the brain surveillance market6 Market6 Brain Surveillance, Through Product6.1 Introduction6.2 Devices6.3 Accessories7 Brain Surveillance Market, through a Medical Condition7.1 Introduction7.2 Traumatic Brain Damage7.3 Stroke7.4 Headache Disorders 7.6 Sleep Disorders 7.7 Parkinson’s Disease 7.8 Epilepsy 7. Nine Huntington’s Disease 7.10 Other Diseases 8 Brain Surveillance Market, According to end user 8.1 Introduction 8.2 Hospitals 8.3 Neurology Centers 8.4 Outpatient Surgery Centers (ASCs) and Clinics 8. five diagnostic centers 8.6 Other end users nine Brain Surveillance Market, across region nine.1 Introduction nine.2 North America nine.3 Companies in Europe mentioned

Reseek and Markets also offers custom searches that offer a targeted, complete and personalized search.

Leave a Comment

Your email address will not be published. Required fields are marked *